BriaCell Therapeutics Corp (NASDAQ:BCTX)’s traded shares stood at 0.48 million during the latest session, with the company’s beta value hitting 1.50. At the last check
BriaCell Therapeutics Corp (NASDAQ:BCTX) has a beta value of 1.49 and has seen 2.33 million shares traded in the last trading session. The company, currently
BriaCell Therapeutics Corp (NASDAQ:BCTX) has a beta value of 1.49 and has seen 2.2 million shares traded in the last trading session. The BCTX stock
During the recent session, BriaCell Therapeutics Corp (NASDAQ:BCTX)’s traded shares were 0.91 million, with the beta value of the company hitting 1.49. At the last
In the last trading session, 1.9 million shares of the BriaCell Therapeutics Corp (NASDAQ:BCTX) were traded, and its beta was 1.46. Most recently the company’s
In the last trading session, 3.51 million shares of the BriaCell Therapeutics Corp (NASDAQ:BCTX) were traded, and its beta was 1.47. Most recently the company’s
BriaCell Therapeutics Corp (NASDAQ:BCTX)’s traded shares stood at 0.85 million during the last session, with the company’s beta value hitting 1.47. At the close of
In the last trading session, 1.58 million BriaCell Therapeutics Corp (NASDAQ:BCTX) shares changed hands as the company’s beta touched 1.46. With the company’s per share
In the last trading session, 3.11 million BriaCell Therapeutics Corp (NASDAQ:BCTX) shares changed hands as the company’s beta touched 1.46. With the company’s per share
In last trading session, BriaCell Therapeutics Corp (NASDAQ:BCTX) saw 1.13 million shares changing hands with its beta currently measuring 1.38. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
